Prawo i regulacje · 20/11/2018

Lipomed Files Application to Import Controlled Substances

Lipomed has submitted an application to the U.S. government to import controlled substances, a process that requires regulatory approval from the Drug Enforcement Administration (DEA). The application is part of Lipomed's efforts to expand its product offerings and improve patient access to certain medications.